Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceIntermittent preventive treatment for malaria in children living in areas with seasonal transmissionChemoprophylaxis and intermittent treatment for preventing malaria in childrenArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaAcquired immunity to malariaDuration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infantsIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenFrom strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, GhanaModelling the epidemiological impact of intermittent preventive treatment against malaria in infants.A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique.Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern TanzaniaIncrease in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.WHO policy development processes for a new vaccine: case study of malaria vaccines.Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan AfricaIncreased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in GhanaStatistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea.A simple method for defining malaria seasonalityCluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications.Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).Clinical malaria in African pregnant women.Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali.
P2860
Q21032450-E803B2D8-702D-4D55-93DD-CE555E60CF56Q21032527-13ADC130-0DDE-42FC-B1B0-7F995FAEB35FQ24243240-DB144018-2AB8-47EF-A135-3A3334ADA84EQ24614989-0436317B-D69C-477A-8E27-8D621EF477B9Q24651173-E2764404-FF51-4A32-8218-2D36E9270F29Q28473083-B4DB64F8-2AF1-415E-A73A-929CB82B2444Q28473566-08B05A7B-1811-4AA5-BEE9-B5E3A0AD07B6Q28474404-D3CA8B93-C4C5-426D-84CC-511E1F96D533Q28477679-7ACEE97E-81B0-4B6C-9C8D-5ACC8224FD86Q30483321-E8352870-66C9-4395-AD73-FEC18EE6406CQ33327356-ABF09E09-25B2-4720-AD27-1F18EFCC804FQ33336570-0A55E6C0-D566-48C0-A0C8-F479357AFC3EQ33351939-860DF8D7-773F-4073-BD9B-439AEB3272E3Q33411580-908BC3C1-6037-4CF9-9192-82C87DFEBB3FQ33645358-6B80C391-0CCE-4AF6-A6D3-48571081F86BQ33691573-15B0FEE8-39E1-443F-A743-0C9277A82DC6Q33817569-51770EB7-81C1-4ADC-B8AE-DE497E03CE9EQ33964491-57FBB425-5268-451E-A0EF-FEED4B681B92Q34008911-64A8E3D3-899A-4210-9BF6-3512F40690EBQ34025033-5F6BFC93-1D89-44ED-907A-C1C1302720A5Q34128601-7260BB8B-6B6A-49FE-9E28-C6CE6D13C5B2Q34142179-AC2A7AFD-4C47-4503-AA6A-4C91F5AD1F86Q34271078-46BB8038-67C8-4281-BA32-226B0F5D3429Q34405184-7AAC8D1C-1662-4113-B195-BCABC967E0F6Q34576841-FE8EF3A3-36C0-404D-B31C-231C1D528473Q34660009-88A42C42-4AD3-48E8-A34D-593835402A2CQ34960038-F5C03671-D2A6-4D8F-85D0-C9CB16C007D8Q35052855-21CFC0E1-5726-4A7F-B0DF-710EEFE4255AQ35198729-8BE4201D-0BA5-4B5F-BDB4-832A772DCB81Q35228689-16A5239C-8409-4FF0-B71D-C078562C9C49Q35573556-9760D61F-5056-485C-A6EC-F8321E08B7B1Q35575256-21E77AF1-4478-4DD3-96AD-BCE43903E5ECQ35680383-A0304B68-AE83-430E-B3A0-87656BFB8F23Q35739071-4C2C85F3-13AF-4F13-B946-A300E157F05FQ36094775-D1D9E927-2AF7-4EFC-BFA5-FC8757411627Q36178132-860BC5F5-4B0B-4660-AC40-C75BEEE6391EQ36447040-04A02CA1-B9C1-4B11-8499-7BECF5D96C39Q36496472-498BFA42-9620-44B0-BDB0-4E7614E76241Q36786675-52A6FA59-7DC9-4668-B95A-B734AFE29BC6Q36817781-CB153A1B-FC3D-4DBB-8F4E-51CB93F5EAB5
P2860
Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@en
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@nl
type
label
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@en
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@nl
prefLabel
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@en
Intermittent preventive treatm ...... zed, placebo-controlled trial.
@nl
P2093
P50
P356
P1476
Intermittent preventive treatm ...... ized, placebo-controlled trial
@en
P2093
Betuel Sigauque
Carlota Dobaño
Eusebio Macete
Martinho DgeDge
Pedro Aide
Pedro Alonso
Samuel Mabunda
Sergi Sanz
P304
P356
10.1086/505431
P407
P577
2006-06-30T00:00:00Z